Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

United Therapeutics

United Therapeutics
1996 FOUNDED
PUBLIC STATUS
801-900 EMPLOYEES
UTHR STOCK SYMBOL
12 INVESTMENTS
$77.51 SHARE PRICE (As of Friday Closing)
Description

United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The firm is a market leader in two of the three primary drugs classes used to treat PAH. Nearly all of its sales are generated within the United States. United also markets a pediatric oncology drug.

Website
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 1040 Spring Street
  • Silver Spring, MD 20910
  • United States

+1 (301) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore United Therapeutics’s full profile, request a free trial.

United Therapeutics Stock Performance

52 wk Range Market Cap Prev. Close EPS Average Volume Shares
$76.52 - $130.00 $3.4B $77.94 -$3.37 712K 43.8M

United Therapeutics Financials Summary

In Thousands,
USD
TTM
31-Mar-2019
FY 2018
31-Dec-2018
FY 2017
31-Dec-2017
FY 2016
31-Dec-2016
Enterprise Value 3,985,002 4,088,444 5,353,175 5,146,362
Revenue 1,601,200 1,627,800 1,725,300 1,598,800
EBITDA (167,200) 780,100 798,600 1,092,200
Net Income (149,900) 589,200 417,900 713,700
Total Assets 3,726,700 3,401,000 2,879,400 2,325,600
Total Debt 1,050,000 250,000 250,000 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

United Therapeutics Valuation and Funding

Deal Type Date Amount Post-Val Valuation/
EBITDA
Debt Status

This information is reserved for PitchBook Platform users. To explore United Therapeutics‘s full profile, request access.

Request full access to PitchBook

United Therapeutics Competitors (21)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
ACADIA Pharmaceuticals Failed Transaction (M&A) San Diego, CA 000 00000 000000&0
0000000 Formerly VC-backed Boston, MA 0000 000000000
0000000 Pending Transaction (M&A) Summit, NJ 0000 000.00 000000&0 000.00
00 0000000 Formerly Accelerator/Incubator backed Paris, France 000 000.00 000000000 000.00
0000000 0000000000 Corporate Backed or Acquired Allschwil, Switzerland 000 00.000 00000000000 00.000
To view this company’s complete list of competitors, request access »

United Therapeutics Investments & Acquisitions (12)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
000000000 00000000 04-Sep-2018 000000000000000000 00000 Therapeutic Devices 0000000 000000000 00.0
0000000000 15-Feb-2018 00000 00000 00 00000 Biotechnology
000 00000000000 08-Jan-2018 00000 00000 00 000.00 Laboratory Services (Healthcare)
0000000 000000 04-Jan-2018 000000000 00000000 Biotechnology
Respira Therapeutics 11-Apr-2017 Later Stage VC 000.00 Therapeutic Devices
To view this company’s complete investment and acquisition history, request access »

United Therapeutics Exits (3)

Company Name Exit Date Exit Type Exit Size Status Buyers
00000000000 26-Dec-2013 00000 00000 00 000 Completed
  • 2 buyers
00000000 0000000 27-Oct-2008 00000 00000 00 000 Completed
  • 6 buyers
Medicomp 29-Dec-2000 Merger/Acquisition 0000 Completed
To view this company’s complete exits history, request access »

United Therapeutics Subsidiaries (3)

Company Name Industry Location Founded
SteadyMed Therapeutics Therapeutic Devices San Ramon, CA 2005
000000000 Biotechnology Blacksburg, VA 0000
0000 0000000000000 Surgical Devices Silver Spring, MD 0000
To view this company’s complete subsidiary history, request access »

United Therapeutics Executive Team (10)

Name Title Board
Seat
Contact
Info
Michael Benkowitz President & Chief Operating Officer
James Edgemond Chief Financial Officer & Treasurer
Paul Mahon JD Executive Vice President, General Counsel & Corporate Secretary
Betsy Eades Senior Associate, Business Development
Christopher Patusky Lead Independent Vice Chairman of the Board

4 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

United Therapeutics Board Members (10)

Name Representing Role Since Contact
Info
Christopher Causey Self Board Member 000 0000
Christopher Patusky United Therapeutics Lead Independent Vice Chairman of the Board 000 0000
Katherine Klein United Therapeutics Independent Director 000 0000
Louis Sullivan MD Self Independent Director 000 0000
Martine Rothblatt Ph.D Self Founder, Chairman & Chief Executive Officer 000 0000

1 Former Board Member

You’re viewing 5 of 10 board members. Get the full list »